The impact of comorbidity on outcomes

ORL

Volumn 66, Issue 4, 2004, Pages 180-185

  Piccirillo, Jay F ^a,b   Costas, Irene ^a  

^a BARNES JEWISH HOSPITAL   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Comorbidity; Outcomes research; Prognosis

Indexed keywords

CLINICAL RESEARCH; COMORBIDITY; CORRELATION ANALYSIS; DATA BASE; DISEASE SEVERITY; DOCTOR PATIENT RELATION; HOSPITAL BILLING; HUMAN; INTERMETHOD COMPARISON; INTERVIEW; MEDICAL RECORD; MORTALITY; OUTCOMES RESEARCH; PATIENT INFORMATION; POPULATION RESEARCH; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; REVIEW; SCORING SYSTEM; SELF REPORT; STATISTICAL ANALYSIS; STATISTICAL MODEL;

COMORBIDITY; HUMANS; LARYNGEAL NEOPLASMS; MOUTH NEOPLASMS; OUTCOME ASSESSMENT (HEALTH CARE); PHARYNGEAL NEOPLASMS; TREATMENT OUTCOME;

EID: 5644293045     PISSN: 03011569     EISSN: None     Source Type: Journal    
DOI: 10.1159/000079875     Document Type: Review

References (25)

1. Feinstein AR: The pre-therapeutic classification of co-morbidity in chronic disease. J Chronic Dis 1970;23:455-469.
2. Katz JN, Chang LC, Sangha O, Fossel AH, Bates DW: Can comorbidity be measured by questionnaire rather than medical record review? Med Care 1996;34:73-84.
3. Silliman RA, Lash TL: Comparison of interview-based and medical-record-based indices of comorbidity among breast cancer patients. Med Care 1999;37:339-349.
4. Fan VS, Au D, Heagerty P, Deyo RA, McDonell MB, Fihn SD: Validation of case-mix measures derived from self-reports of diagnoses and health. J Clin Epidemiol 2002;55:371-380.
5. Kaplan MH, Feinstein AR: The importance of classifying initial co-morbidity in evaluating the outcome of diabetes mellitus. J Chronic Dis 1974;27:387-404.
6. Charlson ME, Pompei P, Ales KL, MacKenzie CR: A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40:373-383.
7. Greenfield S, Apolone G, McNeil BJ, Cleary PD: The importance of co-existent disease in the occurrence of postoperative complications and one-year recovery in patients undergoing total hip replacement. Comorbidity and outcomes after hip replacement. Med Care 1993;31:141-154.
8. Johnston AS, Piccirillo JF, Creech CM, Littenberg B, Jeffe D, Spitznagel ELJ: Validation of a comorbidity education program. J Reg Manag 2001;28:125-131.
9. Piccirillo JF, Costas I, Claybour P, Borah AJ, Grove L, Jeffe D: The measurement of comorbidity by cancer registries. J Reg Manag 2003;30:8-14.
10. Klabunde CN, Warren JL, Legler JM: Assessing comorbidity using claims data: An overview. Med Care 2002;40(8 suppl):26-35.
11. Deyo RA, Cherkin DC, Ciol MA: Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613-619.
12. Romano PS, Roos LL, Luft HS, Jollis JG, Doliszny K: A comparison of administrative versus clinical data: Coronary artery bypass surgery as an example. Ischemic Heart Disease Patient Outcomes Research Team. J Clin Epidemiol 1994;47:249-260.
13. Ghali WA, Hall RE, Rosen AK, Ash AS, Moskowitz MA: Searching for an improved clinical comorbidity index for use with ICD-9-CM administrative data. J Clin Epidemiol 1996;49:273-278.
14. Cleves MA, Sanchez N, Draheim M: Evaluation of two competing methods for calculating Charlson's comorbidity index when analyzing short-term mortality using administrative data. J Clin Epidemiol 1997;50:903-908.
15. Kieszak SM, Flanders WD, Kosinski AS, Shipp CC, Karp H: A comparison of the Charlson Comorbidity Index derived from medical record data and administrative billing data. J Clin Epidemiol 1998;52:137-142.
16. Justice AC, Covinsky KE, Berlin JA: Assessing the generalizability of prognostic information. Ann Intern Med 1999;130:515-524.
17. Potosky AL, Riley GF, Lubitz JD, Mentnech RM, Kessler LG: Potential for cancer related health services research using a linked Medicare-tumor registry database. Med Care 1993;31:732-748.
18. Romano PS: Asking too much of administrative data? J Am Coll Surg 2003;196:337-338.
19. Elixhauser A, Steiner C, Harris R, Coffey RM: Comorbidity measures for use with administrative data. Med Care 1998;36:8-27.
20. Ellis RP, Pope GC, Iezzoni L, Ayanian JZ, Bates DW, Burstin H, et al: Diagnosis-based risk adjustment for Medicare capitation payments. Health Care Financ Rev 1996;17:101-128.
21. Bach PB, Cramer LD, Warren JL, Begg CB: Racial differences in the treatment of early-stage lung cancer. N Engl J Med 1999;341:1198-1205.
22. Romano PS, Roos LL, Jollis JG: Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol 1993;46:1075-1090.
23. Klabunde CN, Potosky AL, Legler JM, Warren JL: Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-1267.
24. Piccirillo JF, Wells CK, Sasaki CT, Feinstein AR: New clinical severity staging system for cancer of the larynx. Five-year survival rates. Ann Otol Rhinol Laryngol 1994;103:83-92.
25. Fleming ST, Rastogi A, Dmitrienko A, Johnson KD: A comprehensive prognostic index to predict survival based on multiple comorbidities. Med Care 1999;37:601-614.